PTKFY OTC
PT Kalbe Farma Tbk
1W: +4.4%
1M: -1.6%
3M: -1.5%
YTD: -40.3%
1Y: -42.4%
3Y: -69.1%
5Y: -55.4%
$8.56
+0.46 (+5.68%)
Weekly Expected Move ±9.2%
$7
$8
$9
$9
$10
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$29.43T
+8.8% ▲
5Y CAGR: +7.7%
Total Liabilities
$4.84T
+22.9% ▲
5Y CAGR: +6.3%
Shareholders Equity
$22.79T
+6.4% ▲
5Y CAGR: +7.5%
Cash & Investments
$4.87T
+43.2% ▲
5Y CAGR: +8.5%
Total Debt
$559.2B
-9.6% ▼
5Y CAGR: -7.3%
Net Debt
-$4.16T
-59.3% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $5.21T | $6.22T | $3.95T | $3.23T | $4.72T |
| Short-Term Investments | $188.3B | $258.9B | $145.3B | $165.5B | $143.1B |
| Cash & ST Investments | $5.40T | $6.48T | $4.10T | $3.40T | $4.87T |
| Net Receivables | $3.59T | $3.55T | $4.79T | $4.65T | $5.01T |
| Inventory | $3.60T | $5.09T | $7.03T | $6.79T | $6.50T |
| Other Current Assets | $421.7B | $613.4B | $831.0B | $887.7B | $77.8B |
| Total Current Assets | $13.08T | $15.71T | $16.71T | $15.92T | $17.19T |
| Property, Plant & Equip. | $8.47T | $8.30T | $8.35T | $8.07T | $8.76T |
| Goodwill & Intangibles | $693.9B | $1.16T | $1.53T | $1.78T | $2.35T |
| Long-Term Investments | -$65.0B | $44.3B | $239.2B | $450.8B | $374.5B |
| Other Non-Current Assets | $305.6B | $358.4B | $289.6B | $844.0B | $639.3B |
| Total Non-Current Assets | $9.49T | $9.95T | $10.53T | $11.14T | $12.24T |
| Total Assets | $22.56T | $25.67T | $27.24T | $27.06T | $29.43T |
| — Liabilities — | |||||
| Accounts Payable | $1.24T | $1.67T | $2.00T | $1.69T | $1.89T |
| Short-Term Debt | $344.3B | $70.0B | $829.3B | $278.3B | $322.1B |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $1.17T | $784.4B | $747.6B | $717.8B | $772.5B |
| Total Current Liabilities | $3.18T | $3.53T | $4.43T | $3.24T | $4.19T |
| Long-Term Debt | $722.8B | $490.3B | $287.0B | $298.3B | $195.0B |
| Other Non-Current Liab. | $320.3B | $500M | $368.5B | $375.6B | $370.4B |
| Total Non-Current Liabilities | $1.11T | $866.1B | $712.9B | $694.4B | $653.5B |
| Total Liabilities | $4.29T | $4.40T | $5.14T | $3.94T | $4.84T |
| — Equity — | |||||
| Common Stock | $468.8B | $468.8B | $468.8B | $468.8B | $468.8B |
| Retained Earnings | $16.62T | $18.47T | $20.19T | $21.51T | $22.94T |
| Accumulated OCI | $348.3B | $678.5B | $767.0B | $447.3B | $0 |
| Total Stockholders Equity | $17.41T | $19.58T | $20.39T | $21.42T | $22.79T |
| Total Liabilities & Equity | $22.56T | $25.67T | $27.24T | $27.06T | $29.43T |
| — Key Metrics — | |||||
| Total Debt | $1.16T | $626.2B | $1.17T | $618.5B | $559.2B |
| Net Debt | -$4.05T | -$5.59T | -$2.78T | -$2.61T | -$4.16T |
| Total Investments | $123.3B | $303.3B | $384.5B | $616.3B | $517.6B |